Tonix Meds Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TONIX MEDS, and when can generic versions of TONIX MEDS drugs launch?
TONIX MEDS has two approved drugs.
There are ten US patents protecting TONIX MEDS drugs.
There are ninety patent family members on TONIX MEDS drugs in twenty-nine countries.
Drugs and US Patents for Tonix Meds
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | 8,440,631 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | 9,283,280 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | 11,337,962 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Tonix Meds | ZEMBRACE SYMTOUCH | sumatriptan succinate | SOLUTION;SUBCUTANEOUS | 208223-001 | Jan 28, 2016 | RX | Yes | No | 11,364,224 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Tonix Meds Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 116549389 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2011014797 | ⤷ Sign Up |
United Kingdom | 2600026 | ⤷ Sign Up |
Brazil | PI0923403 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.